Clinical Trial Update: Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD) [NA]

View source ↗

Summary

Clinical trial evaluating the effect of sevelamer on glucose tolerance and insulin sensitivity in chronic kidney disease was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Hyperphosphatemia
• Insulin Resistance

Drugs mentioned

• Sevelamer (sevelamer hydrochloride)

Snippet

Sponsor: Karolinska Institutet | Conditions: Kidney Failure, Chronic, End-Stage Renal Disease | NA | Status: WITHDRAWN